BofA-Merrill downgrades India`s Dr. Reddy`s to `neutral`

BofA-Merrill downgrades India's Dr. Reddy's to 'neutral'

Last Updated: Fri, Feb 15, 2013 04:11 hrs
An investor watches the share index at a local share and stock market in the northern Indian city of Chandigarh

Bank of America-Merrill Lynch downgraded its rating on India's Dr Reddy's Laboratories Ltd to "neutral" from "buy", saying "a slight" increase in core profit estimates was being offset by a fading U.S. drug pipeline and moderating growth.

"We expect multiples to be capped due to modest growth prospects," the investment bank said in an email to clients on Friday.

More from Sify: